title: The fibronectin production is increased by thrombospondin via activation of TGF-beta in cultured human mesangial cells.
abstract: Thrombospondin (TSP) is a multifunctional glycoprotein that is synthesized by a variety of cells including mesangial cells (MCs). To clarify the effect of TSP on the pathogenesis of diabetic nephropathy, we studied the effect of glucose concentrations on TSP synthesis in cultured human MCs. Thereafter, the effects of TSP on the activation of transforming growth factor beta (TGF-beta) and fibronectin production were investigated in MCs. Incubating MCs with elevated glucose levels for 6 days resulted in an increase in TSP synthesis, measured by an enzyme-linked immunosorbent assay, both in culture media and cell layers. Treatment of MCs with TSP (final concentrations 1 and 5 microg/ml) for 24 h resulted in an increase (1.3- and 2.1-fold, respectively) in active TGF-beta, which was determined with an enzyme-linked immunosorbent assay using TGF-beta-soluble receptor type II, in the culture media without having any effect on the production of total TGF-beta. Exposure of MCs to TSP caused enhancement of fibronectin production in both media and cell layers in a TSP dose-dependent manner with the maximum at a TSP concentration of 1 microg/ml. The TSP-induced increase in fibronectin production from MCs was completely prevented by concomitant treatment with 10 microg/ml anti-TGF-beta neutralizing antibody. These results indicate that the TSP production is promoted by a high ambient glucose concentration in human MCs and that TSP, in turn, causes an increase in fibronectin production via activation of TGF-beta.
authors.affiliation: 2nd Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Tada
authors.forename: S
authors.initials: S
authors.lastname: Isogai
mesh_terms: D000906:Antibodies / Q000494:pharmacology; D002478:Cells, Cultured; D003094:Collagen / Q000494:pharmacology; D003928:Diabetic Nephropathies / Q000503:physiopathology; D005353:Fibronectins / Q000378:metabolism*; D005920:Glomerular Mesangium / Q000187:drug effects*; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D007797:Laminin / Q000494:pharmacology; D019699:Thrombospondins / Q000494:pharmacology*; D016212:Transforming Growth Factor beta / Q000276:immunology / Q000494:pharmacology*
chemical_list: D000906:Antibodies; D005353:Fibronectins; D007797:Laminin; D019699:Thrombospondins; D016212:Transforming Growth Factor beta; D003094:Collagen; D005947:Glucose